Foresite Capital Management IV as of Sept. 30, 2018
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 21 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed (INSM) | 11.9 | $36M | 1.8M | 20.22 | |
| Myokardia | 10.9 | $33M | 511k | 65.20 | |
| Biohaven Pharmaceutical Holding | 10.5 | $32M | 851k | 37.55 | |
| Immunomedics | 8.4 | $26M | 1.2M | 20.83 | |
| Arbutus Biopharma (ABUS) | 8.3 | $25M | 2.7M | 9.45 | |
| Cymabay Therapeutics | 7.3 | $22M | 2.0M | 11.08 | |
| Rhythm Pharmaceuticals (RYTM) | 6.7 | $20M | 697k | 29.17 | |
| Replimune Group (REPL) | 6.5 | $20M | 1.2M | 16.10 | |
| Optinose (OPTN) | 5.9 | $18M | 1.5M | 12.43 | |
| Ascendis Pharma A S (ASND) | 5.7 | $17M | 245k | 70.86 | |
| Alder Biopharmaceuticals | 5.5 | $17M | 1.0M | 16.65 | |
| Omeros Corporation (OMER) | 2.9 | $8.7M | 356k | 24.41 | |
| Aclaris Therapeutics (ACRS) | 2.5 | $7.7M | 530k | 14.52 | |
| Eidos Therapeutics | 1.7 | $5.2M | 525k | 9.98 | |
| Xenon Pharmaceuticals (XENE) | 1.7 | $5.1M | 386k | 13.20 | |
| Arcus Biosciences Incorporated (RCUS) | 1.4 | $4.1M | 295k | 13.94 | |
| Gritstone Oncology Ord (GRTS) | 0.8 | $2.5M | 175k | 14.24 | |
| Kiniksa Pharmaceuticals | 0.8 | $2.4M | 95k | 25.50 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.5 | $1.4M | 50k | 28.65 | |
| Uniqure Nv (QURE) | 0.1 | $388k | 11k | 36.43 | |
| Verona Pharma Plc ads (VRNA) | 0.0 | $104k | 8.3k | 12.53 |
